DXCM vs LAFAR
DexCom Inc (DXCM) versus LaFayette Acquisition Corp. Rights (LAFAR) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
LaFayette Acquisition Corp. Rights (LAFAR) common stock listed on NASDAQ.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
LAFAR does not have a complete income-statement cache yet.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. LAFAR currently screens at market cap $0.
Not investment advice. Open the DXCM and LAFAR stock pages for the full models.
Not investment advice.